Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions

Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions

Etoricoxib is a non-steroidal anti-inflammatory drug with high selectivity for cyclooxygenase 2 (COX-2), exerting a pronounced anti-inflammatory effect with fewer adverse events when compared to COX-1 inhibitors. The present study aimed to evaluate the bioequivalence between two etoricoxib-coated ta...

Full description

Bibliographic Details
Main Authors: Jessica Meulman, Marcelo Gomes Davanço, Débora Renz Barreto Vianna, Thalita Martins da Silva, Fernando Costa, Fernando Bastos Canton Pacheco, Milla Emke de Oliveira, Celso Francisco Pimentel Vespasiano
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Pharmaceutics
Subjects:
etoricoxib
anti-inflammatory agents
non-steroidal
cyclooxygenase 2 inhibitors
bioequivalence
pharmacokinetics
Online Access:https://www.mdpi.com/1999-4923/15/11/2569

Internet

https://www.mdpi.com/1999-4923/15/11/2569

Similar Items